2014
DOI: 10.1016/j.juro.2014.02.866
|View full text |Cite
|
Sign up to set email alerts
|

Mp22-18 Identification of Novel Gene Expression Markers for Bladder Cancer Diagnostics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Based on the Open Targets Platform, TFDP1 was related to various human diseases, including respiratory (LUAD and LUSC), thoracic, reproductive system, gastrointestinal, immune system, and endocrine system diseases. TFDP1 was overexpressed in breast and bladder cancer, confirmed by quantitative real-time polymerase chain reaction (qRT-PCR) and could be a potential biomarker [ 43 , 44 ]. Jibrim et al used real-time polymerase chain reaction (PCR) to evaluate TFDP1 expression levels and found that TFDP1 expression was underexpressed in women’s endometrium [ 45 ].…”
Section: Discussionmentioning
confidence: 99%
“…Based on the Open Targets Platform, TFDP1 was related to various human diseases, including respiratory (LUAD and LUSC), thoracic, reproductive system, gastrointestinal, immune system, and endocrine system diseases. TFDP1 was overexpressed in breast and bladder cancer, confirmed by quantitative real-time polymerase chain reaction (qRT-PCR) and could be a potential biomarker [ 43 , 44 ]. Jibrim et al used real-time polymerase chain reaction (PCR) to evaluate TFDP1 expression levels and found that TFDP1 expression was underexpressed in women’s endometrium [ 45 ].…”
Section: Discussionmentioning
confidence: 99%
“…Previously, KIFC1 was reported to be highly expressed in several types of cancer including ovarian cancer ( Pawar et al, 2014 ), breast cancer ( Pannu et al, 2015 ), bladder cancer ( Alekseev et al, 2014 ), lung cancer ( Grinberg-Rashi et al, 2009 ), among others ( Chan, 2011 ). However, the exact mechanism of KIFC1 overexpression remains unclear ( Pannu et al, 2015 ).…”
Section: Analysis Of Clinical Datamentioning
confidence: 99%
“…It is reported that KIFC1 is abundantly and widely expressed in cancer cells of the ovary [22], breast [23], bladder [24], lung [25], kidney [26] and other cancers [26]. The special status of KIFC1 in cancer cells is, therefore, well established.…”
Section: Evidence For Applicability Of Kifc1-related Systems In Anti-mentioning
confidence: 99%